Corcept Therapeutics director David L. Mahoney sells 103,606 shares worth $12.26 million
CORT•Director sells shares in August transactions
- Corcept director David L. Mahoney sold 103,606 shares on Aug. 18.
- Sales were priced at $117.47 to $119.64, weighted-average by tranche.
- Holdings in a family trust fell to 1,133,539 shares following the transactions.
